Showing all 10 results
Clindipine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Light-Shielded Cardiovascular Tablet, packed exclusively in highly secure, opaque Alu-Alu blister strips to ensure the absolute chemical stability of the highly photosensitive active ingredient.
Active Ingredient Strength Primary Clinical Function Cilnidipine USP/Ph.Eur. 5 mg The Geriatric & Titration Anchor: The definitive starting dose utilized for elderly patients or those with mild essential hypertension to prevent sudden hypotensive episodes. Cilnidipine USP/Ph.Eur. 10 mg The Global Maintenance Standard: The standardized daily therapeutic payload utilized for the vast majority of adult patients requiring chronic 24-hour blood pressure control. Cilnidipine USP/Ph.Eur. 20 mg The Severe Refractory Macrodose: Utilized strictly for severe, uncontrolled hypertension where the 10mg dose has failed to achieve target blood pressure metrics. Excipients Microcrystalline Cellulose / Lactose Monohydrate / Croscarmellose Sodium / Hypromellose / Magnesium Stearate / Opaque Polymeric Film (Titanium Dioxide base) Diluent / Densifier / Superdisintegrant / Binder / Lubricant / Protective Light Shield (Engineered specifically utilizing a dense, titanium dioxide-heavy film coat. Cilnidipine is intensely sensitive to UV and visible light; this opaque coating guarantees 100% of the active molecule survives to reach the patient’s systemic circulation) *Pack Sizes: 10×10 Opaque Alu-Alu Blisters (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
Darifenacin Prolonged Release Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrophilic Matrix Prolonged-Release Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute physical stability of the controlled-release polymer.
Active Ingredient Strength Primary Clinical Function Darifenacin Hydrobromide USP/Ph.Eur.
(Equivalent to Darifenacin base)7.5 mg (PR) The Standard Titration & Geriatric Anchor: The definitive, highly efficacious starting and maintenance dose utilized for the vast majority of patients to control OAB symptoms with minimal side effects. Darifenacin Hydrobromide USP/Ph.Eur. 15 mg (PR) The Severe Refractory Macrodose: High-efficacy therapeutic payload utilized strictly for patients who require greater symptom relief and have demonstrated high tolerability to the 7.5 mg dose. Excipients Hypromellose (HPMC) / Dibasic Calcium Phosphate / Magnesium Stearate / Polyethylene Glycol / Titanium Dioxide / Premium Polymeric Film Hydrophilic PR Matrix / Diluent / Lubricant / Plasticizer / Opaque Film (Engineered specifically utilizing high-viscosity Hypromellose. Upon contact with gastrointestinal fluids, the tablet hydrates to form a thick, gelatinous outer layer that strictly controls the diffusion of the highly soluble hydrobromide salt over a 24-hour period) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic urological dispensing regimens).
Domperidone & Paracetamol Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapid-Burst Macrodose FDC Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or heavy-gauge Alu-Alu blister strips to ensure the absolute chemical stability of both active pharmaceutical ingredients.
Active Ingredient Strength Primary Clinical Function Domperidone Maleate USP/Ph.Eur. 10 mg The Antiemetic/Prokinetic Anchor: The micro-dose peripheral D2 antagonist required to halt vomiting and rapidly accelerate gastric emptying. Paracetamol (Acetaminophen) USP/Ph.Eur. 500 mg The Central Analgesic Payload: The massive therapeutic payload required to elevate the central pain threshold and crush acute migraine pain. Excipients Microcrystalline Cellulose / Crospovidone / Maize Starch / Povidone K-30 / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / Binder / Lubricant / Heavy Film-Coating (Engineered specifically utilizing advanced “Rapid-Burst” superdisintegrants to ensure the massive 510mg active core shatters instantly upon contact with gastric fluid, guaranteeing hyper-fast pain relief while masking the bitter taste of the APIs) *Pack Sizes: 10×10 Blisters (Optimized specifically for rapid-response outpatient pain management and acute neurology dispensing).
DOMPERIDONE & RANITIDINE TABLETS
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapid-Release FDC Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of both active pharmaceutical ingredients.
Active Ingredient Strength Primary Clinical Function Domperidone Maleate USP/Ph.Eur. 10 mg The Antiemetic/Prokinetic Anchor: The micro-dose peripheral D2 antagonist required to halt nausea and rapidly accelerate gastric emptying. Famotidine USP/Ph.Eur. 20 mg The Acid Suppressor (NDMA-Free): The highly potent, structurally stable H2-receptor antagonist required to crush basal and food-stimulated gastric acid secretion. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone K-30 / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / Binder / Lubricant / Heavy Film-Coating (Engineered specifically utilizing advanced rapid-burst disintegrants to ensure the tablet dissolves instantly in the stomach for fast relief, heavily coated to protect the APIs from environmental degradation) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for high-volume, rapid-turnover acute GI dispensing).
Pantoprazole & Domperidone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Dual-Release Capsule or Bilayer Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly acid-labile Pantoprazole and the SR polymer network.
Active Ingredient Strength Primary Clinical Function Pantoprazole Sodium Sesquihydrate USP/Ph.Eur. 40 mg (Enteric-Coated) Global Clinical Standard: Profound, 24-hour suppression of gastric acid production. Domperidone Maleate BP/Ph.Eur. 30 mg (Sustained-Release) Continuous 24-hour peripheral prokinetic action to accelerate gastric emptying and prevent nausea. Excipients Methacrylic Acid Copolymer / Hypromellose (HPMC) / Mannitol / Magnesium Stearate Enteric Barrier Coating / Hydrophilic SR Polymer Matrix / Diluent (Engineered specifically to perfectly isolate the two APIs and control their entirely separate intestinal dissolution rates) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, high-compliance 14-to-28 day chronic gastroenterology dispensing regimens).
Ranitidine and Domperidone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density Alu-PVC blister strips to ensure the absolute chemical stability of both active pharmaceutical ingredients.
Active Ingredient Strength Primary Clinical Function Famotidine USP/Ph.Eur. 20 mg Global Clinical Standard: Safe, NDMA-free H2 antagonist for baseline acid suppression. Domperidone Maleate BP/Ph.Eur. 10 mg (Base Equivalent) Peripheral prokinetic and anti-emetic to accelerate gastric emptying and prevent reflux. Excipients Microcrystalline Cellulose / Maize Starch / Crospovidone / Magnesium Stearate Diluent / Binder / Superdisintegrant / Lubricant (Engineered for immediate gastric dissolution and synchronized absorption) *Pack Sizes: 10×10 Blisters (Optimized specifically for high-turnover retail OTC and acute gastroenterology dispensing).
Ranolazine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Polymeric Matrix Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute stability of the modified-release polymers.
Active Ingredient Strength Primary Clinical Function Ranolazine INN/Ph.Eur. 500 mg (Extended-Release) Global Clinical Standard: Base initiation dose for chronic angina management (taken twice daily). Ranolazine INN/Ph.Eur. 1000 mg (Extended-Release) Advanced maintenance dose for severe, refractory angina requiring maximum cellular relaxation. Excipients Hypromellose (HPMC) / Methacrylic Acid Copolymer / Microcrystalline Cellulose / Magnesium Stearate Hydrophilic Polymer Matrix / Enteric Matrix / Diluent (Engineered to form a viscous gel layer that controls the strict 12-hour drug diffusion rate) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 60 (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
Saxagliptin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the sensitive active pharmaceutical ingredient.
Active Ingredient Strength Primary Clinical Function Saxagliptin (as Hydrochloride) INN/Ph.Eur. 2.5 mg Target dose for patients with moderate/severe renal impairment or those taking strong CYP3A4 inhibitors. Saxagliptin (as Hydrochloride) INN/Ph.Eur. 5 mg Global Clinical Standard: Maximum adult daily dose for the maintenance of Type 2 Diabetes. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate Diluent / Binder / Superdisintegrant (Engineered for immediate gastric dissolution and optimal bioavailability) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for high-compliance 30-day chronic metabolic dispensing regimens).
SILODOSIN 8 MG TABLET
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the active pharmaceutical ingredient.
Active Ingredient Strength Primary Clinical Function Silodosin INN/Ph.Eur. 8 mg Global Clinical Standard: Maximum adult daily dose for the rapid relief of lower urinary tract symptoms (LUTS) associated with BPH. Excipients Mannitol / Pregelatinized Starch / Sodium Stearyl Fumarate / Hypromellose / Titanium Dioxide Diluent / Binder / Lubricant / Film-Coating (Engineered for highly synchronized gastric dissolution and optimal bioavailability) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for high-compliance 30-day urology dispensing regimens).
Solifenacin Succinate Tablets
FreeA Solifenacin Succinate tablet is an antimuscarinic (anticholinergic) medication used to treat symptoms of an overactive bladder, such as frequent or urgent urination and urinary incontinence.
